NCT04881383View on ClinicalTrials.gov

Development and Validation of DM and Pre-DM Risk Prediction Model

CompletedOBSERVATIONAL

Enrollment

1,014

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

September 30, 2023

Conditions

Diabetes MellitusPre Diabetes

Interventions

DIAGNOSTIC_TEST

OGTT and HbA1c

An investigation form will be given to the patient to attend an approved private laboratory for blood pressure, weight, height, waist and hip circumferences, and a blood test on OGTT, HbA1c, complete blood count (CBC) and lipid profile within three months

Trial Locations (1)

Unknown

Department of Family Medicine & Primary Care, LKS Faculty of Medicine, University of Hong Kong, Hong Kong

All Listed Sponsors

lead

The University of Hong Kong

OTHER

NCT04881383 - Development and Validation of DM and Pre-DM Risk Prediction Model | Biotech Hunter | Biotech Hunter